These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7275609)

  • 21. Offsite surveillance around the nevada test site July-December 1966.
    Radiat Data Rep; 1972 Apr; 13(4):227-36. PubMed ID: 5067417
    [No Abstract]   [Full Text] [Related]  

  • 22. RADIOACTIVE EFFLUENT MONITORING AT THE NEVADA TEST SITE FOLLOWING NUCLEAR DETONATIONS. UCRL-12272.
    GOTCHY RL
    Hazard Control Qual Rep; 1964 Dec; 36():1-27. PubMed ID: 24547346
    [No Abstract]   [Full Text] [Related]  

  • 23. Reply to comments on estimates of external gamma exposure.
    Anspaugh LR; Church BW
    Health Phys; 1988 Sep; 55(3):581-2. PubMed ID: 3170215
    [No Abstract]   [Full Text] [Related]  

  • 24. Leukemia in the Nevada 'Smoky' bomb test.
    Bond VP; Hamilton LD
    JAMA; 1980 Oct; 244(14):1610. PubMed ID: 7420667
    [No Abstract]   [Full Text] [Related]  

  • 25. Overview of the National Cancer Institute's activities related to exposure of the public to fallout from the Nevada Test Site.
    Wachholz BW
    Health Phys; 1990 Nov; 59(5):511-4. PubMed ID: 2211110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer incidence in an area of radioactive fallout downwind from the Nevada Test Site.
    Johnson CJ
    JAMA; 1984 Jan; 251(2):230-6. PubMed ID: 6690781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimates of doses from global fallout.
    Bouville A; Simon SL; Miller CW; Beck HL; Anspaugh LR; Bennett BG
    Health Phys; 2002 May; 82(5):690-705. PubMed ID: 12003019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re: Thyroid cancer rates and (131)I doses from Nevada atmospheric nuclear bomb tests.
    Archer VE
    J Natl Cancer Inst; 1999 Aug; 91(16):1423-5. PubMed ID: 10451455
    [No Abstract]   [Full Text] [Related]  

  • 29. Childhood leukemia and fallout from the Nevada nuclear tests.
    Land CE; McKay FW; Machado SG
    Science; 1984 Jan; 223(4632):139-44. PubMed ID: 6691139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukemia in Utah and radioactive fallout from the Nevada test site. A case-control study.
    Stevens W; Thomas DC; Lyon JL; Till JE; Kerber RA; Simon SL; Lloyd RD; Elghany NA; Preston-Martin S
    JAMA; 1990 Aug; 264(5):585-91. PubMed ID: 2366297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nevada test fallout and radioiodine in milk.
    LAPP RE
    Science; 1962 Sep; 137(3532):756-8. PubMed ID: 14462359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid disease associated with exposure to the Nevada nuclear weapons test site radiation: a reevaluation based on corrected dosimetry and examination data.
    Lyon JL; Alder SC; Stone MB; Scholl A; Reading JC; Holubkov R; Sheng X; White GL; Hegmann KT; Anspaugh L; Hoffman FO; Simon SL; Thomas B; Carroll R; Meikle AW
    Epidemiology; 2006 Nov; 17(6):604-14. PubMed ID: 17028502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ORERP (Off-Site Radiation Exposure Review Project) internal dose estimates for individuals.
    Ng YC; Anspaugh LR; Cederwall RT
    Health Phys; 1990 Nov; 59(5):693-713. PubMed ID: 2211124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meteorological modeling of arrival and deposition of fallout at intermediate distances downwind of the Nevada Test Site.
    Cederwall RT; Peterson KR
    Health Phys; 1990 Nov; 59(5):593-601. PubMed ID: 2211118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests.
    Gilbert ES; Tarone R; Bouville A; Ron E
    J Natl Cancer Inst; 1998 Nov; 90(21):1654-60. PubMed ID: 9811315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating internal dose due to ingestion of radionuclides from Nevada Test Site fallout.
    Kirchner TB; Whicker FW; Anspaugh LR; Ng YC
    Health Phys; 1996 Oct; 71(4):487-501. PubMed ID: 8830750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of the Department of Energy's Off-Site Radiation Exposure Review Project (ORERP).
    Church BW; Wheeler DL; Campbell CM; Nutley RV; Anspaugh LR
    Health Phys; 1990 Nov; 59(5):503-10. PubMed ID: 2211109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cohort study of thyroid disease in relation to fallout from nuclear weapons testing.
    Kerber RA; Till JE; Simon SL; Lyon JL; Thomas DC; Preston-Martin S; Rallison ML; Lloyd RD; Stevens W
    JAMA; 1993 Nov; 270(17):2076-82. PubMed ID: 8411574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimates of fallout in the continental U.S. from Nevada weapons testing based on gummed-film monitoring data.
    Beck HL; Helfer IK; Bouville A; Dreicer M
    Health Phys; 1990 Nov; 59(5):565-76. PubMed ID: 2211116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of radioactive fallout at the Nevada test site on the chromosomes of the pocket mouse.
    Towner JW
    Health Phys; 1965 Dec; 11(12):1569-71. PubMed ID: 5884551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.